Mightier
PrivateLast Round
Series B
Dec 13, 2021
Total Funding Raised
$28.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Mightier is a digital health company that provides a bioresponsive video game platform designed to help children build emotional regulation. Developed at Boston Children's Hospital and Harvard Medical School, the program utilizes a heart rate monitor that adjusts game difficulty in real-time, enabling children to learn calming techniques. The platform, aimed at children aged 6-14, addresses challenges such as anxiety, ADHD, and anger. The company originated as a research program, became an independent entity named Neuromotion Labs in 2014, and later rebranded its product to Mightier in 2018.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Gaming, Patient Engagement, Health IoT, Subscription Commerce
Business Model
B2C
Customer Profile
Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Mightier Comparables
Compare Mightier with similar companies based on industry and business-model similarity.
Mightier Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 13, 2021 | ||||
| Grant | Feb 8, 2021 | ||||
| Series A Extension | Sep 27, 2019 | ||||
| Series A | May 1, 2019 | ||||
| Seed | Jun 19, 2018 |
Key People
Founding team and executive leadership
Mightier Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Slow Ventures | Series A, Seed |
| National Institute of Mental Health | Grant |
| DigiTx Partners | Series B |
| Sony Ventures Corporation | Series B |
| Founder Collective | Seed, Series A |
| Project 11 Ventures | Series A |
| Foxkiser | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Monthly visitors increased 36% MoM.
- Apr 1, 2026
Trials at Boston Children's, Harvard, and Mass General show program efficacy matching medications.
Mightier Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Mightier's valuation, stock price, and market status.